Galmed Pharmaceuticals
GLMD
GLMD
23 hedge funds and large institutions have $4.47M invested in Galmed Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
37% less capital invested
Capital invested by funds: $7.05M → $4.47M (-$2.58M)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
23
Holding in Top 10
–
Calls
$31K
Puts
$16K
Top Buyers
| 1 | +$62K | |
| 2 | +$42K | |
| 3 | +$20K | |
| 4 |
Morgan Stanley
New York
|
+$7.16K |
| 5 |
JPMorgan Chase & Co
New York
|
+$1K |
Top Sellers
| 1 | -$1.59M | |
| 2 | -$244K | |
| 3 | -$66.9K | |
| 4 |
VF
Virtu Financial
New York
|
-$65K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$61.8K |